Immunovaccine, Inc. - Product Pipeline Review - 2013

Market: Pharmaceuticals and Healthcare

Global, 41 pages report, published by Global Markets Direct

Keywords : Current R&D Portfolio of Immunovaccine, Inc.; Immunovaccine, Inc. - Key Therapeutics; Immunovaccine, Inc. - Pipeline Overview and Promising Molecules; Immunovaccine, Inc. - News; Immunovaccine, Inc. - Latest Updates; Immunovaccine, Inc. - Pipeline; Immunovaccine, Inc. - Discontinued/Dormant Projects

Report ThumbnailAugust-2013
Immunovaccine, Inc. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Immunovaccine, Inc. - Product Pipeline Review - 2013” provides data on the Immunovaccine, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Immunovaccine, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Immunovaccine, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Immunovaccine, Inc. - Brief Immunovaccine, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Immunovaccine, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Immunovaccine, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Immunovaccine, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Immunovaccine, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Immunovaccine, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Immunovaccine, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Immunovaccine, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Immunovaccine, Inc. and identify potential opportunities in those areas.
  • List of Figures
  • Immunovaccine, Inc. - Pipeline by Indication, 2013 7
  • Immunovaccine, Inc. - Pipeline by Stage of Development, 2013 9
  • Immunovaccine, Inc. - Monotherapy Products in Pipeline, 2013 10
  • Immunovaccine, Inc. - Pipeline By Therapeutic Class, 2013 28
  • Immunovaccine, Inc. - Pipeline By Route of Administration, 2013 31
  • List of Tables
  • Immunovaccine, Inc., Key Information 5
  • Immunovaccine, Inc., Key Facts 5
  • Immunovaccine, Inc. - Pipeline by Indication, 2013 8
  • Immunovaccine, Inc. - Pipeline by Stage of Development, 2013 9
  • Immunovaccine, Inc. - Monotherapy Products in Pipeline, 2013 10
  • Immunovaccine, Inc. - Phase II, 2013 11
  • Immunovaccine, Inc. - Phase I, 2013 12
  • Immunovaccine, Inc. - Preclinical, 2013 13
  • Immunovaccine, Inc. - Discovery, 2013 14
  • Immunovaccine, Inc. - Pipeline By Therapeutic Class, 2013 29
  • Immunovaccine, Inc. - Pipeline By Target, 2013 30
  • Immunovaccine, Inc. - Pipeline By Route of Administration, 2013 31
  • Immunovaccine, Inc. - Recent Pipeline Updates, 2013 32
  • Immunovaccine, Inc. - Dormant Developmental Projects,2013 37
  • Immunovaccine, Inc. - Discontinued Pipeline Products, 2013 38
  • Table of Contents
  • Table of Contents 2
  • List of Tables 4
  • List of Figures 4
  • Immunovaccine, Inc. Snapshot 5
  • Immunovaccine, Inc. Overview 5
  • Key Information 5
  • Key Facts 5
  • Immunovaccine, Inc. - Research and Development Overview 6
  • Key Therapeutic Areas 6
  • Immunovaccine, Inc. - Pipeline Review 9
  • Pipeline Products by Stage of Development 9
  • Pipeline Products - Monotherapy 10
  • Immunovaccine, Inc. - Pipeline Products Glance 11
  • Immunovaccine, Inc. Clinical Stage Pipeline Products 11
  • Phase II Products/Combination Treatment Modalities 11
  • Phase I Products/Combination Treatment Modalities 12
  • Immunovaccine, Inc. - Early Stage Pipeline Products 13
  • Preclinical Products/Combination Treatment Modalities 13
  • Discovery Products/Combination Treatment Modalities 14
  • Immunovaccine, Inc. - Drug Profiles 15
  • Anthrax Vaccine 15
  • Product Description 15
  • Mechanism of Action 15
  • R&D Progress 15
  • Cocaine Addiction Vaccine 16
  • Product Description 16
  • Mechanism of Action 16
  • R&D Progress 16
  • Dengue Fever Vaccine 17
  • Product Description 17
  • Mechanism of Action 17
  • R&D Progress 17
  • DPX-0907 18
  • Product Description 18
  • Mechanism of Action 18
  • R&D Progress 18
  • DPX-Survivac 19
  • Product Description 19
  • Mechanism of Action 19
  • R&D Progress 19
  • Hepatitis B Vaccine 20
  • Product Description 20
  • Mechanism of Action 20
  • R&D Progress 20
  • Herpes Simplex Virus 2 Vaccine 21
  • Product Description 21
  • Mechanism of Action 21
  • R&D Progress 21
  • HIV Vaccine 22
  • Product Description 22
  • Mechanism of Action 22
  • R&D Progress 22
  • Malaria Vaccine 23
  • Product Description 23
  • Mechanism of Action 23
  • R&D Progress 23
  • Pandemic Influenza Vaccine 24
  • Product Description 24
  • Mechanism of Action 24
  • R&D Progress 24
  • Respiratory Syncytial Virus Vaccine 25
  • Product Description 25
  • Mechanism of Action 25
  • R&D Progress 25
  • Tuberculosis Vaccine 26
  • Product Description 26
  • Mechanism of Action 26
  • R&D Progress 26
  • Vaccine For Multifiloviruses 27
  • Product Description 27
  • Mechanism of Action 27
  • R&D Progress 27
  • Immunovaccine, Inc. - Pipeline Analysis 28
  • Immunovaccine, Inc. - Pipeline Products by Therapeutic Class 28
  • Immunovaccine, Inc. - Pipeline Products By Target 30
  • Immunovaccine, Inc. - Pipeline Products by Route of Administration 31
  • Immunovaccine, Inc. - Recent Pipeline Updates 32
  • Immunovaccine, Inc. - Dormant Projects 37
  • Immunovaccine, Inc. - Discontinued Pipeline Products 38
  • Discontinued Pipeline Product Profiles 38
  • DPX-Pseudomonas 38
  • Immunovaccine, Inc. - Locations And Subsidiaries 39
  • Head Office 39
  • Appendix 40
  • Methodology 40
  • Coverage 40
  • Secondary Research 40
  • Primary Research 40
  • Expert Panel Validation 40
  • Contact Us 41
  • Disclaimer 41

Please select a license type

Share

Related Products

Global Markets DirectImmunovaccine, Inc. - Product Pipeline Review - 2013Product ThumbnailImmunovaccine, Inc. - Product Pipeline Review - 2013, Industry ReportProduct #: 113359
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved